WANBURY
Back to All Ratios
|
WANBURY Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 4.22 | 5.84 | 0.92 | 1.26 | 0.70 |
What is the latest EV/CE ratio of WANBURY ?
Year | EV/CE |
---|---|
Mar2024 | 4.22 |
Mar2023 | 5.84 |
Mar2022 | 0.92 |
Mar2021 | 1.26 |
Mar2020 | 0.70 |
How is EV/CE of WANBURY Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 4.22 | -27.74 | |
Mar2023 | 5.84 | 534.78 | |
Mar2022 | 0.92 | -26.98 | |
Mar2021 | 1.26 | 80.00 | |
Mar2020 | 0.7 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹827.4 Cr | -1.4% | -10.4% | 12.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -1.4% |
-10.4% |
12.8% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses